Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C37449
http://purl.obolibrary.org/obo/NCIT_C37449
|
|---|---|
| Preferred Name | Survivin Antigen |
| Definitions |
A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis. |
|---|---|
| prefLabel | Survivin Antigen
|
| label | Survivin Antigen
|
| PDQ_Closed_Trial_Search_ID | 346072
|
| code | C37449
|
| Has_Target | |
| prefixIRI | NCIT:C37449
|
| in_subset |
See more
See less
|
| Display_Name | Survivin Antigen
|
| Preferred_Name | Survivin Antigen
|
| Contributing_Source | CTRP
|
| Maps_To | Survivin Antigen
|
| NCI_Drug_Dictionary_ID | 346072
|
| Legacy Concept Name | Survivin_Antigen
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 346072
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Immunologic Factor
|
| UMLS_CUI | C1515097
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |